About this trial
This study aims to explore the use of a hydrocolloid dressing (DuoDERM EXTRA THIN) as an alternative to the current standard of care. The dressing would be applied immediately after surgery and removed at a post-operative week 1 appointment. The dressing would eliminate the need for antibiotic ointment application and reduce the burden of post-operative care on the patient.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients >18 years of age
follow-up at specified intervals (1 week/6 week/3 months) in an office setting
can give informed consent
no patients will be excluded on the basis of gender, ethnicity, or religious background
Disqualifiers
Patients <18 years of age or >100
allergy to pectin, gelatin, and sodium carboxymethylcellulose
adults with impaired consent capacity
incarcerated individuals.
Trial design
Parallel
Treatments tested in this trial
Hydrocolloid Wound Dressing
Deviceone time hydrocolloid dressing application
Treatment groups
Trial outcomes
Primary outcomes
Number of participants with wound dehiscence
YES/NO type question if wound dehiscence is present after removal of the patch
Secondary outcomes
Patient and Observer Scar Assessment Scale
Patient and Observer Scar Assessment Scale filled out by both patient and provider at postoperative visit of both HCD Dressing and ointment. This survey is scaled from 0-10, with 0 being normal skin and 10 being very different skin. Lower scores are desired on this survey.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Janice Hernandez, MD
Lead sponsor
University of Kentucky
Sponsor institution